Venture Capital
The accelerator seeks to work with innovative drug developers at different stages of development
1
VinFast founder to inject another $1.5b in exchange for R&D assets
2
Vivo Capital launches new accelerator platform to leverage China's biopharma strengths
3
How indian regulators struggled to contain Jane Street's trading machine
4
India Digest: Shivalik Small Finance Bank, Refold AI secure funding
5
Aditya Birla Group’s TMRW House of Brands secures $50m from ServiceNow Ventures
More Stories
Two frontrunners emerge as Axiata said to be nearing sale of Link Net
Granite Asia reups in Singaporean oatmilk brand Oatside
Thailand’s B.Grimm hires banker for potential fundraise
EQT to sell Australian IT firm Nexon Asia to Adamantem Capital
Sea Ltd uses Shopee’s hyperlocal playbook to power Garena’s recovery
Earnings and Results
Tencent has significantly ramped up its AI investments.
Climate Tech & ESG
Power reforms introduced this year removed a guaranteed rate of return for renewable energy projects.
Analysis
Judicial authorities lack the power to directly dispose of digital assets.
Deals
They have received creditor claims totalling $45 billion.
IPOs & Markets
Its HK$9.25 offer price is a 9.9% premium to Kangji’s last closing price.
The company’s total revenue rose 17.9% to $1.17 billion during the quarter.
Founder and chairman Chang Liang holds around 60% of the company.
The Hong Kong exchange’s rule for US-style confidential filings was implemented in May.
Our coverage of the governance crisis brewing at CROWDE was popular among readers.
